49 results
8-K
EX-10.1
AXLA
Axcella Health Inc.
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option
8-K
EX-10.1
AXLA
Axcella Health Inc.
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
8-K
EX-10.1
dnnruco 8cko7gknquld
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
8-K
EX-10.1
lzsqkzgj 3vt
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-10.1
zyy9 66y7zt
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
fh7aj6ewivrk4vd9
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
7rhdv6vera3c8hhtjs
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm